Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Urinary Bladder Neoplasms: HELP
Igor Moskalev
Based on 11 articles published since 2010
(Why 11 articles?)
||||
Expertise Level
The expertise of Igor Moskalev ranks in the Graphical view (beta)
Work Locations
Details
Most likely:    University of British Columbia      
2019
  • Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Department of Urology, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany. · Division of Urology, National Cancer Center Hospital, Tokyo, Japan. · Department of Urology and Hemodialysis/Apheresis, Akita University School of Medicine, Akita, Japan. · Pubmed 31012113
  • 1 Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. · 2 Department of Radiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. · 3 Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. · 4 Department of Pathology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. · 5 The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · 6 XVir Therapeutics GmbH, Munich, Germany. · Pubmed 29916265
2018
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia Vancouver, BC, Canada. · Universitätsmedizin der Johannes Gutenberg-Universität Mainz Mainz, Germany. · Pubmed 30697580
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Department of Urology, University Hospital, Tuebingen, Germany. · Department of Urology, University of Bern, Bern, Switzerland. · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. · University of Tuebingen, Tuebingen, Germany. · Departments of Clinical Pharmacology and Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany. · Southampton General Hospital, Southampton, United Kingdom. · GenomeDx Biosciences, Vancouver, Canada. · Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Pubmed 30262589
2017
  • Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Urology, University of Bern, Bern, Switzerland. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. · Department of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark. · Zymeworks Inc., Vancouver, BC, Canada. · Vancouver Prostate Centre, Vancouver, BC, Canada. · Department of Urology, University Hospital of Southampton, Hampshire, UK. · Department of Medical Oncology, University Hospital of Southampton, Hampshire, UK. · Department of Urology, University of Bern, Bern, Switzerland. · GenomeDx Biosciences, Inc., Vancouver, BC, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Zymeworks Inc., Vancouver, BC, Canada. Electronic address: · Pubmed 28408175
  • Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. · Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Alligator Bioscience AB, Lund, Sweden. · Department of Immunotechnology, Lund University, Lund, Sweden. · Pubmed 27873300
2016
  • Department of Pathology, Anatomy and Cell Biology and The Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Department of Urology and Biology and The Prostate Cancer Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. · Department of Health and Endocrinology, University Magna Graecia of Catanzaro, Catanzaro, Italy. · Pubmed 27220888
2015
  • Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia (TH, RS, HZO, WJ, IM, SA, TD, TT, NL, LF, PCB), Vancouver, British Columbia, Canada · Department of Urology, Institute of Biomedical and Health Science, Hiroshima University (TH), Hiroshima, Japan. · Pubmed 26047983
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Urology, Johannes Gutenberg University, Mainz, Germany. · Department of Cancer Endocrinology, BC Cancer Agency, Vancouver, BC, Canada. · Research and Development, GenomeDx Biosciences, Vancouver, BC, Canada. · Pubmed 26041878
2014
  • Department of Urologic Sciences, University of British Columbia. · Department of Urologic Sciences, University of British Columbia; · Pubmed 24561487
2013
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Pubmed 23555699
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 11 total) written by Igor Moskalev about Urinary Bladder Neoplasms:

  • Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancer. 2019
  • The Oncolytic Adenovirus XVir-N-31 as a Novel Therapy in Muscle-Invasive Bladder Cancer. 2019
  • Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) model. 2018
  • Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer. 2018
  • An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer. 2017
  • Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer. 2017
  • Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin. 2016
  • Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder Cancer. 2015
  • Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies. 2015
  • Minimally invasive establishment of murine orthotopic bladder xenografts. 2014
Show List of Full Article Records
Google Searches

Learn more about Igor Moskalev using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of British Columbia
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of British Columbia
2019
  • Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Department of Urology, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany. · Division of Urology, National Cancer Center Hospital, Tokyo, Japan. · Department of Urology and Hemodialysis/Apheresis, Akita University School of Medicine, Akita, Japan. · Pubmed 31012113
  • 1 Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. · 2 Department of Radiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. · 3 Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. · 4 Department of Pathology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. · 5 The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · 6 XVir Therapeutics GmbH, Munich, Germany. · Pubmed 29916265
2018
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia Vancouver, BC, Canada. · Universitätsmedizin der Johannes Gutenberg-Universität Mainz Mainz, Germany. · Pubmed 30697580
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Department of Urology, University Hospital, Tuebingen, Germany. · Department of Urology, University of Bern, Bern, Switzerland. · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. · University of Tuebingen, Tuebingen, Germany. · Departments of Clinical Pharmacology and Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany. · Southampton General Hospital, Southampton, United Kingdom. · GenomeDx Biosciences, Vancouver, Canada. · Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Pubmed 30262589
2017
  • Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Urology, University of Bern, Bern, Switzerland. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. · Department of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark. · Zymeworks Inc., Vancouver, BC, Canada. · Vancouver Prostate Centre, Vancouver, BC, Canada. · Department of Urology, University Hospital of Southampton, Hampshire, UK. · Department of Medical Oncology, University Hospital of Southampton, Hampshire, UK. · Department of Urology, University of Bern, Bern, Switzerland. · GenomeDx Biosciences, Inc., Vancouver, BC, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Zymeworks Inc., Vancouver, BC, Canada. Electronic address: · Pubmed 28408175
  • Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. · Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Alligator Bioscience AB, Lund, Sweden. · Department of Immunotechnology, Lund University, Lund, Sweden. · Pubmed 27873300
2016
  • Department of Pathology, Anatomy and Cell Biology and The Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Department of Urology and Biology and The Prostate Cancer Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. · Department of Health and Endocrinology, University Magna Graecia of Catanzaro, Catanzaro, Italy. · Pubmed 27220888
2015
  • Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia (TH, RS, HZO, WJ, IM, SA, TD, TT, NL, LF, PCB), Vancouver, British Columbia, Canada · Department of Urology, Institute of Biomedical and Health Science, Hiroshima University (TH), Hiroshima, Japan. · Pubmed 26047983
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Urology, Johannes Gutenberg University, Mainz, Germany. · Department of Cancer Endocrinology, BC Cancer Agency, Vancouver, BC, Canada. · Research and Development, GenomeDx Biosciences, Vancouver, BC, Canada. · Pubmed 26041878
2014
  • Department of Urologic Sciences, University of British Columbia. · Department of Urologic Sciences, University of British Columbia; · Pubmed 24561487
2013
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Pubmed 23555699
Yearly article counts 02221211000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.